AstraZeneca (AZN.L) has warned it could relocate its vaccine manufacturing site from the UK to the U.S. amid a deadlock with the new Labour government over plans to cut state aid, the Financial Times reported, opens new tab on Thursday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,